Publications by authors named "Djamila Issa"

Claim this Profile
C
Challenges in predicting outcomes for watch and wait follicular lymphoma patients: insights into clinical, pathological, and molecular factors.
Eva A M Hesius, James P Stewart, Leonie I Kroeze, Ellen van der Spek, Djamila Issa

Leuk Lymphoma· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fatigue, Neuropathy and Psychological Distress and Their Association With Health-Related Quality of Life in Survivors of Diffuse Large B-Cell Lymphoma: A Prospective Cohort Study and Comparison With a Normative Population.
Suzanne I M Neppelenbroek, Afke Ekels, Marie José Kersten, Djamila E Issa, Noortje Thielen

Hematol Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atezolizumab consolidation in patients with high-risk diffuse large B-cell lymphoma in complete remission after R-CHOP.
Marcel Nijland, Djamila E Issa, Johanna A A Bult, Dries Deeren, Gerjo A Velders

Blood Adv· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutational profile dynamics in follicular lymphoma and large cell transformation.
Eva A M Hesius, Wendy B C Stevens, James P Stewart, Leonie I Kroeze, Ellen van der Spek, Djamila Issa

J Clin Pathol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The course of self-perceived cognitive functioning among patients with lymphoma and the co-occurrence with fatigue and psychological distress.
Afke Ekels, Simone Oerlemans, Sanne B Schagen, Djamila E Issa, Noortje Thielen

J Cancer Surviv· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of comorbidity on health-related quality of life in newly diagnosed patients with lymphoma or multiple myeloma: results from the PROFILES-registry.
Afke Ekels, Lonneke V van de Poll-Franse, Djamila E Issa, Mels Hoogendoorn, Marten R Nijziel

Ann Hematol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to DA-EPOCH-R is associated with activation of 'fitter' cytotoxic T cells in patients with newly diagnosed double and triple hit high-grade B-cell lymphoma.
A Vera De Jonge, Wassilis S C Bruins, Carolien Duetz, Charlotte L B M Korst, Rosa Rentenaar, Djamila Issa

Haematologica· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative effectiveness of 6x R-CHOP21 versus 6x R-CHOP21 + 2 R for patients with advanced-stage diffuse large B-cell lymphoma.
Carolien C H M Maas, David van Klaveren, Müjde Durmaz, Otto Visser, Djamila E Issa

Blood Cancer J· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health care utilization up to 11 years after diagnosis among patients with a hematologic malignancy and its association with socioeconomic position.
Afke Ekels, Lonneke V van de Poll-Franse, Djamila E Issa, Margriet Oosterveld, René van der Griend

J Cancer Surviv· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line venetoclax combinations versus chemoimmunotherapy in fit patients with chronic lymphocytic leukaemia (GAIA/CLL13): 4-year follow-up from a multicentre, open-label, randomised, phase 3 trial.
Moritz Fürstenau, Arnon P Kater, Sandra Robrecht, Julia von Tresckow, Can Zhang, Djamila E Issa

Lancet Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment and outcomes for patients with relapsed or refractory diffuse large B-cell lymphoma: a contemporary, nationwide, population-based study in the Netherlands.
Elise R A Pennings, Müjde Durmaz, Otto Visser, Eduardus F M Posthuma, Djamila E Issa

Blood Cancer J· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fixed-duration venetoclax plus obinutuzumab improves quality of life and geriatric impairments in FCR-unfit patients with CLL.
Lina van der Straten, Claudia A M Stege, Sabina Kersting, Kazem Nasserinejad, Julie Dubois, Djamila E Issa

Blood· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
No sex differential in relative survival among older patients with DLBCL treated with R-CHOP21: a population-based study.
Emma E Geerdes, Müjde Durmaz, Pieternella J Lugtenburg, Martine E D Chamuleau, Otto Visser, Djamila E Issa

Blood Adv· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ixazomib, daratumumab and low-dose dexamethasone in intermediate-fit patients with newly diagnosed multiple myeloma: an open-label phase 2 trial.
Kaz Groen, Claudia A M Stege, Kazem Nasserinejad, Koen de Heer, Roel J W van Kampen, Djamila E Issa

EClinicalMedicine· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity of the 13-Valent Pneumococcal Conjugated Vaccine Followed by the 23-Valent Polysaccharide Vaccine in Chronic Lymphocytic Leukemia.
Sabine Haggenburg, Hannah M Garcia Garrido, Iris M J Kant, Hanneke M Van der Straaten, Fransien De Boer, Djamila Issa

Vaccines (Basel)· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
R-CEOP as first-line treatment for anthracycline-ineligible patients with diffuse large B-cell lymphoma.
Diana Al-Sarayfi, Frederik O Meeuwes, Müjde Durmaz, Djamila E Issa, Rolf E Brouwer

Blood Cancer J· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistent symptoms of fatigue, neuropathy and role-functioning impairment among indolent non-Hodgkin lymphoma survivors: A longitudinal PROFILES registry study.
Afke Ekels, Lonneke V van de Poll-Franse, Eduardus F M Posthuma, Jacobien Kieffer, Djamila E Issa

Br J Haematol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venetoclax consolidation after fixed-duration venetoclax plus obinutuzumab for previously untreated chronic lymphocytic leukaemia (HOVON 139/GiVe): primary endpoint analysis of a multicentre, open-label, randomised, parallel-group, phase 2 trial.
Sabina Kersting, Julie Dubois, Kazem Nasserinejad, Johan A Dobber, Clemens Mellink, Djamila E Issa

Lancet Haematol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time trends in primary therapy and relative survival of diffuse large B-cell lymphoma by stage: a nationwide, population-based study in the Netherlands, 1989-2018.
Müjde Durmaz, Otto Visser, Eduardus F M Posthuma, Rolf E Brouwer, Djamila E Issa

Blood Cancer J· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Web-Based Return of Individual Patient-Reported Outcome Results Among Patients With Lymphoma: Randomized Controlled Trial.
Simone Oerlemans, Lindy Paulina Johanna Arts, Jacobien M Kieffer, Judith Prins, Mels Hoogendoorn, Djamila Issa

J Med Internet Res· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A population-based study on different regimens of R-CHOP in patients with newly diagnosed DLBCL in The Netherlands.
Djamila E Issa, Avinash G Dinmohamed, Marielle J Wondergem, Hedwig M Blommestein, Peter C Huijgens

Leuk Lymphoma· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Web-Based Self-Management for Patients With Lymphoma: Assessment of the Reach of Intervention of a Randomized Controlled Trial.
Lindy P J Arts, Simone Oerlemans, Eduardus F M Posthuma, Djamila E Issa, Margriet Oosterveld

J Med Internet Res· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rituximab and the risk of transformation of follicular lymphoma: a retrospective pooled analysis.
Massimo Federico, María Dolores Caballero Barrigón, Luigi Marcheselli, Vittoria Tarantino, Martina Manni, Djamila Issa

Lancet Haematol· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment and relative survival in very elderly patients with DLBCL in The Netherlands: a population-based study, 1989 to 2015.
Avinash G Dinmohamed, Djamila E Issa, Marjolein W M van der Poel, Harry C Schouten, Pieternella J Lugtenburg

Blood Adv· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends in incidence, treatment and survival of aggressive B-cell lymphoma in the Netherlands 1989-2010.
Djamila E Issa, Saskia A M van de Schans, Martine E D Chamuleau, Henrike E Karim-Kos, Marielle Wondergem

Haematologica· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis